Solution conformation of an immunogenic peptide derived from the principal neutralizing determinant of the HIV-2 envelope glycoprotein gp125

Folding and Design

Volumn 1, Issue 2, 1996, Pages 157-165

  Campbell, A Patricia ^a,b   Sykes, Brian D ^b   Norrby, Erling ^c   Assa Munt, Nuria ^a,d   Dyson, H Jane ^a  

^a SCRIPPS RESEARCH INSTITUTE   (United States)

^b UNIVERSITY OF ALBERTA   (Canada)

^c KAROLINSKA INSTITUTE   (Sweden)

^d BURNHAM INSTITUTE   (United States)

Author keywords

HIV 2; Peplide vaccine; Peptide conformation

Indexed keywords

DISULFIDE; HIV 2 ENVELOPE PROTEIN GP125; HIV-2 ENVELOPE PROTEIN GP125; HUMAN IMMUNODEFICIENCY VIRUS ANTIGEN; HUMAN IMMUNODEFICIENCY VIRUS VACCINE; PEPTIDE; PROTEIN PRECURSOR; RECOMBINANT VACCINE; VIRUS ENVELOPE PROTEIN;

AMINO ACID SEQUENCE; ARTICLE; CHEMICAL STRUCTURE; CHEMISTRY; DRUG DESIGN; GENETICS; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS 2; IMMUNOLOGY; MOLECULAR GENETICS; NUCLEAR MAGNETIC RESONANCE SPECTROSCOPY; PROTEIN CONFORMATION; PROTEIN SECONDARY STRUCTURE; SERODIAGNOSIS; STEREOISOMERISM;

AIDS VACCINES; AMINO ACID SEQUENCE; DISULFIDES; DRUG DESIGN; GENE PRODUCTS, ENV; HIV ANTIGENS; HIV-2; HUMANS; MAGNETIC RESONANCE SPECTROSCOPY; MOLECULAR SEQUENCE DATA; MOLECULAR STRUCTURE; NEUTRALIZATION TESTS; PEPTIDES; PROTEIN CONFORMATION; PROTEIN PRECURSORS; PROTEIN STRUCTURE, SECONDARY; STEREOISOMERISM; VACCINES, SYNTHETIC;

EID: 0030334731     PISSN: 13590278     EISSN: None     Source Type: Journal    
DOI: 10.1016/S1359-0278(96)00024-7     Document Type: Article

References (53)

1. Rusche, J.R., et al., & Matthews, T.J. (1988). Antibodies that inhibit fusion of human immunodeficiency virus-infected cells bind a 24-amino acid sequence of the viral envelope gp120. Proc. Natl. Acad. Sci. USA 85, 3198-3202.
2. Goudsmit, J., et al., & Gajdusek, D.C. (1988). Human immunodeficiency virus type 1 neutralization epitope with conserved architecture elicits early type-specific antibodies in experimentally infected chimpanzees. Proc. Natl. Acad. Sci. USA 85, 4478-4482.
3. Palker, T.J., et al., & Haynes, B.F. (1988). Type-specific neutralization of the human immunodeficiency virus with antibodies to env-encoded synthetic peptides. Proc. Natl. Acad. Sci. USA 85, 1932-1936.
4. Javaherian, K., et al., & Matthews, T.J. (1989). Principal neutralizing domain of the human immunodeficiency virus type 1 envelope protein. Proc. Natl. Acad. Sci. USA 86, 6768-6772.
5. Björling, E., et al., & Norrby, E. (1991). Hyperimmune antisera against synthetic peptides representing the glycoprotein of human immunodeficiency virus type 2 can mediate neutralization and antibody-dependent cytotoxic activity. Proc. Natl. Acad. Sci. USA 88, 6082-6086.
6. Björling, E., Chiodi, F., Utter, G. & Norrby, E. (1994). Two neutralizing domains in the V3 region in the envelope glycoprotein gp125 of human immunodeficiency virus type 2.7. Immunol. 152, 1952-1959.
7. LaRosa, G.J., et al., & Putney, S.D. (1990). Conserved sequence and structural elements in the HIV-1 principal neutralizing domain. Science 24, 9932-9935.
8. Matthews, T.J., et al., & Bolognesi, D.P. (1986). Restricted neutralization of divergent human T-lymphotropic virus type III isolates by antibodies to the major envelope glycoprotein. Proc. Natl. Acad. Sci. USA 83, 9709-9713.
9. Putney, S.D., et al., & Bolognesi, D.P. (1986). HTLV-III/LAV-neutralizing antibodies to an E. coli-produced fragment of the virus envelope. Science 234, 1392-1395.
10. Albert, J., et al., & Chiodi, F. (1995). Biological phenotype of HIV-2 isolates correlates with V3 genotype. AIDS Res. Hum. Retrovir. in press.
11. Matsushita, S., Matsumi, S., Yoshimura, K., Morikita, T., Murakami, T. & Takatsuki, K. (1995). Neutralizing monoclonal antibodies against human immunodeficiency virus type 2 gp120. J. Virol. 69, 3333-3340.
12. Chandrasekhar, K., Profy, A.T. & Dyson, H.J. (1991). Solution conformational preferences of immunogenic peptides derived from the principal neutralizing determinant of the HIV-1 envelope glycoprotein gp120. Biochemistry 30, 9187-9194.
13. Zvi, A., Hiller, R. & Anglister, J. (1992). Solution conformation of a peptide corresponding to the principal neutralizing determinant of HIV-1IIIB: a two-dimensional NMR study. Biochemistry 31, 6972-6979.
14. Laczko, I., et al., & Ötvös, L.J. (1992). Synthesis and conformational studies of N-glycosylated analogues of the HIV-1 principal neutralizing determinant. Biochemistry 31, 4282-4288.
15. Wendt, H., Berger, C., Baici, A., Thomas, R.M. & Bosshard, H.R. (1995). Kinetics of folding of leucine zipper domains. Biochemistry 34, 4097-4107.
16. De Lorimier, R., Moody, M.A., Haynes, B.F. & Spicer, L.D. (1994). NMR-derived solution conformations of a hybrid synthetic peptide containing multiple epitopes of envelope protein gp120 from the RF strain of human immunodeficiency virus. Biochemistry 33, 2055-2062.
17. Rini, J.M., Stanfield, R.L, Stura, E.A., Salinas, P.A., Profy, A.T. & Wilson, I.A. (1993). Crystal structure of a human immunodeficiency virus type 1 neutralizing antibody, 50.1, in complex with its V3 loop peptide antigen. Proc. Natl. Acad. Sci. USA 90, 6325-6329.
18. Ghiara, J.B., Stura, E.A., Stanfield, R.L, Profy, A.T. & Wilson, I.A. (1994). Crystal structure of the principal neutralization site of HIV-1. Science 264, 82-85.
19. Waltho, J.P., Feher, V.A., Lerner, R.A. & Wright, P.E. (1989). Conformation of a T cell stimulating peptide in aqueous solution. FEBS Lett. 250, 400-404.
20. Waltho, J.P., Feher, V.A., Merutka, G., Dyson, H.J. & Wright, P.E. (1993). Peptide models of protein folding initiation sites. 1. Secondary structure formation by peptides corresponding to the G- and H-helices of myoglobin. Biochemistry 32, 6337-6347.
21. Dyson, H.J., Rance, M., Houghten, R.A., Lerner, R.A. & Wright, P.E. (1988). Folding of immunogenic peptide fragments of proteins in water solution. 1. Sequence requirements for the formation of a reverse turn. J. Mol. Biol. 201, 161-200.
22. Wüthrich, K. (1986). NMR of Proteins and Nucleic Acids. John Wiley and Sons, New York.
23. Dyson, H.J. & Wright, P.E. (1991). Defining solution conformations of small linear peptides. Annu. Rev. Biophys. Biophys. Chem. 20, 519-538.
24. Wishart, D.S., Sykes, B.D. & Richards, P.M. (1991). Relationship between nuclear magnetic resonance chemical shift and protein secondary structure. J. Mol. Biol. 222, 311-333.
25. Merutka, G., Dyson, H.J. & Wright, P.E. (1995). Peptide proton random coil chemical shifts obtained as a function of temperature and trifluoroethanol concentration. J. Biomol. NMR 5, 14-24.
26. Gagné, S.M., Tsuda, S., Li, M.X., Chandra, M., Smillie, L.B. & Sykes, B.D. (1994). Quantification of the calcium-induced secondary structural changes in the regulatory domain of troponin-C. Protein Sci. 3, 1961-1974.
27. Grathwohl, C. & Wüthrich, K. (1976). The X-Pro peptide bond as an NMR probe for conformational studies of flexible linear peptides. Biopolymers 15, 2025-2041.
28. Yao, J., Feher, V.A., Espejo, B.F., Reymond, M.T., Wright, P.E. & Dyson, H.J. (1994). Stabilization of a type VI turn in a family of linear peptides in water solution. J. Mol. Biol. 243, 736-753.
29. Rose, G.D., Gierasch, L.M. & Smith, J.A. (1985). Turns in peptides and proteins. Adv. Protein Chem. 37, 1-106.
30. Richardson, J.S. (1981). The anatomy and taxonomy of protein structure. Adv. Protein Chem. 34, 167-339.
31. HNα for identification of helical secondary structure. J. Mol. Biol. 180, 741-751.
32. Stanfield, R.L., Fieser, T.M., Lerner, R.A. & Wilson, I.A. (1990). Crystal structures of an antibody to a peptide and its complex with peptide antigen at 2.8 Å. Science 248, 712-719.
33. Rini, J.M., Schulze-Gahmen, U. & Wilson, I.A. (1992). Structural evidence for induced fit as a mechanism for antibody-antigen recognition. Science 255, 959-965.
34. Garcia, K.C., Ronco, P.M., Verroust, P.J., Brünger, A.T. & Amzel, L.M. (1992). Three-dimensional structure of an angiotensin II-Fab complex at 3 A: hormone recognition by an anti-idiotypic antibody. Science 257, 502-507.
35. Shoham, M. (1993). Crystal structure of an anticholera toxin peptide complex at 2.3 Å. J. Mol. Biol. 232, 1169-1175.
36. Tormo, J., Blass, D., Parry, N.R., Rowlands, D., Stuart, D. & Fita, I. (1994). Crystal structure of a human rhinovirus neutralizing antibody complexed with a peptide derived from viral capsid protein VP2. EMBOJ. 13, 2247-2256.
37. Dyson, H.J., Cross, K.J., Houghten, R.A., Wilson, I.A., Wright, P.E. & Lerner, R.A. (1985). The immunodominant site of a synthetic immunogen has a conformational preference in water for a type-II reverse turn. Nature 318, 480-483.
38. Dyson, H.J., Rance, M., Houghten, R.A., Wright, P.E. & Lerner, R.A. (1988). Folding of immunogenic peptide fragments of proteins in water solution. II. The nascent helix. J. Mol. Biol. 201, 201-217.
39. Blumenstein, M., Matsueda, G.R., Timmons, S. & Hawiger, J. (1992). A β-turn is present in the 392-411 segment of the human fibrinogen γ-chain. Effects of structural changes in this segment on affinity to antibody 4A5. Biochemistry 31, 10692-10698.
40. Scherf, T., Hiller, R., Naider, F., Levitt, M. & Anglister, J. (1992). Induced peptide conformations in different antibody complexes: molecular modeling of the three-dimensional structure of peptide-antibody complexes using NMR-derived distance restraints. Biochemistry 31, 6884-6897.
41. McInnes, C., Sönnichsen, F.D., Kay, C.M., Hodges, R.S. & Sykes, B.D. (1993). NMR solution structure and flexibility of a peptide antigen representing the receptor binding domain of Pseudomonas aeruginosa. Biochemistry 32, 13432-13440.
42. Campbell, A.P., McInnes, C., Hodges, R.S. & Sykes, B.D. (1995). Comparison of NMR solution structures of the receptor binding domains of Pseudomonas aeruginosa pili strains PAO, KB7 and PAK: implications for receptor binding and synthetic vaccine design, Biochemistry 34, 16255-16268.
43. Hinds, H.G., et al., & Robinson, J.A. (1991). Synthesis, conformational properties and antibody recognition of peptides containing β-turn mimetics based on α-alkylproline. J. Med. Chem. 34, 1777-1789.
44. Profy, A.T., Saunas, P.A., Eckler, L.I., Dunlop, N.M., Nara, P.L. & Putney, S.D. (1990). Epitopes recognized by the neutralizing antibodies of an HIV-1 infected individual. J. Immunol. 144, 4641-4647.
45. Wong, W.Y., Irwin, R.T., Paranchych, W. & Hodges, R.S. (1992). Antigen-antibody interactions: elucidation of the epitope and strain-specificity of a monoclonal antibody directed against the pilin protein adherence binding domain of Pseudomonas aeruginosa strain K. Protein Sci. 1, 1308-1318.
46. Piantini, U., Serensen, O.W. & Ernst, R.R. (1982). Multiple quantum filters for elucidating NMR coupling networks. J. Am. Chem. Soc. 104, 6800-6801.
47. 1H NMR spectra of proteins via double quantum filtering. Biochem. Biophys. Res. Commun. 117, 479-485.
48. Bax, A. & Davis, D.G. (1985). MLEV-17 based two-dimensional homonuclear magnetization transfer spectroscopy. J. Magn. Reson. 65, 355-360.
49. Rance, M. (1987). Improved techniques for homonuclear rotating-frame and isotropic mixing experiments. J. Magn. Reson. 74, 557-564.
50. Jeener, J., Meier, B.H., Bachmann, P. & Ernst, R.R. (1979). Investigation of exchange processes by two-dimensional NMR spectroscopy. J. Chem. Phys. 71, 4546-4553.
51. Macura, S. & Ernst, R.R. (1980). Elucidation of cross-relaxation in liquids by two-dimensional N.M.R. spectroscopy. Mol. Phys. 41, 95-117.
52. States, D.J., Haberkorn, R.A. & Ruben, D.J. (1982). A two-dimensional nuclear Overhauser experiment with pure absorption phase in four quadrants. J. Magn. Reson. 48, 286-292.
53. 1H spin-spin coupling constants in proteins. Biochem. Biophys. Res. Commun. 113, 967-974.